Business
Brain Scientific Announces First Quarter 2022 Results
Brain Scientific Announces First Quarter 2022 Results.
About this update from Brain Scientific, Inc.
[{"type":"text","content":"\n LAKEWOOD RANCH, Fla., May 13, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific (OTCQB:BRSF) today reports its business highlights and financial results for the first quarter ended March 31, 2022. First Quarter and Recent Highlights Announced its novel neurology products will be presented to the NATO Center of Excellence for Military Medicine as an innovative and potentially life-saving tool for armed service personnel.Expanded its reach to Eastern Europe by partnering with CODICO GmBH – bringing the Company’s revolutionary motion control and automation solutions to Poland, Austria, Hungary, Czech Republic and Slovakia.Joined forces with Micro Technology Group which will deliver the Company’s motion control and automation solutions to OEM manufacturers throughout the northeastern United States.Appointed two senior executives to lead revenue generation efforts.Announced global partnership with a global master agent, advancing innovative neurodiagnostic devices.Partnered with Benson Engineering to deliver affordable micro-precision motors and motion control solutions to the southern U.S.Hosted a webinar on March 17 discussing how miniature precision motors can be disruptive in the market by providing affordable piezoelectric technology.Released a whitepaper outlining the role of its RAS rotary motor in the medical device and high-tech application markets.Collaborated with Electroline Sales, Inc. to offer disruptive motion control technology to Electroline Sales, Inc.’s diverse customer base.Partnered with Motion & Control Sales, Ltd to unite its motion products with cost-effective automation solutions.Entered into an agreement with Applied Mechatronics to deliver affordable micro-precision motors and motion control solutions to the West Coast.Joined forces with STXi Motion to enter the precision motor market in Israel. “2022 is off to a great start, as we’ve significantly expanded the distribution of our products domestically and worldwide and added highly accomplished and experienced senior personnel to lead revenue generation efforts,” said Hassan Kotob, Chairman and CEO of Brain Scientific. “We also recently announced the presentation of our neurology products to the NATO Center of Excellence for Military Medicine, further highlighting the potential of our innov...